VIS954

BIOLOGICAL2 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc.

Conditions

HealthyHealthy Volunteers

Phase 1

A Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VIS954 in Healthy Adult Participants

CompletedNCT06212804

Otsuka Pharmaceutical Development & Commercialization, Inc.Healthy Volunteers

Start: 2023-11-21End: 2024-07-19Updated: 2026-04-24

A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954

CompletedNCT06937593

Otsuka Pharmaceutical Development & Commercialization, Inc.Healthy

Start: 2025-03-13End: 2026-02-03Updated: 2026-06-03